Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Urocidin in BCG-refractory NMIBC
NCT00406068Phase 3Completed
- Sponsor
- Bioniche Life Sciences
- Start
- Nov 2006
- Primary completion
- Jul 2011
- Modality
- Biologic, CWE (Cell wall extract)
- Countries
- 2
01
Overview
A Phase 3 trial of mycobacterial cell wall-DNA complex in Non-muscle-invasive bladder cancer (NMIBC), sponsored by Bioniche Life Sciences. Started Nov 2006; status: completed.
02
Drugs
mycobacterial cell wall-DNA complex
03
Conditions
Non-muscle-invasive bladder cancer (NMIBC)
Beyond the preview
Go deeper on NCT00406068.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00406068.